Bio-Techne (TECH) Shareholders Approve $Merger Agreement With Merck KGaA

gurufocus.com · 2026-09-24

Bio-Techne Corporation (TECH) announced that its shareholders have voted to approve and adopt the previously disclosed Agreement and Plan of Merger with Merck

TickrTrends take: Shareholders of Bio-Techne have approved a merger agreement with Merck KGaA, which represents a significant corporate event that could affect the company's valuation trajectory. Given TickrTrends' current assessment that TECH is undervalued, investors focused on valuation metrics should monitor how this transaction impacts the company's future earnings power and whether the merger price aligns with or diverges from intrinsic value estimates. The consolidation within the healthcare sector could also influence comparable company multiples and industry dynamics that factor into valuation reassessment.

Read the full story at gurufocus.com →